[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"biomarker:kat6a-gene":3},{"name":4,"total":5,"recruiting":5,"trials":6},"KAT6A Gene",3,[7,15,21],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT06638307","A First-in-Human Study of MEN2312 in Adults With Advanced Breast Cancer",[11],"Phase 1","RECRUITING","2026-08-26T02:19:16.454910Z","2026-07-05T05:32:16.765634Z",{"nct_id":16,"title":17,"phases":18,"status":12,"updated_at":19,"content_modified":20},"NCT06177067","Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia",[11],"2026-08-26T02:19:29.119921Z","2026-05-05T02:43:27.978998Z",{"nct_id":22,"title":23,"phases":24,"status":12,"updated_at":26,"content_modified":27},"NCT07540572","A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid Tumors",[25],"Phase 1\u002FPhase 2","2026-08-26T02:18:17.007929Z","2026-05-05T02:43:28.420175Z"]